Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Talk with Patients: Relapsed SCLC and Amrubicin
Author
Howard (Jack) West, MD

A few weeks ago, I gave a talk at a Seattle non-profit called Cancer Lifeline, at which I described some of the highlights of current lung cancer treatment and the direction of ongoing research. I recorded that lecture (which does include some stray sounds in the background), and I thought it would be helpful to make it available to people online.

The talk lasted over an hour, so we're breaking it up into pieces on a discrete topic. The first one is on SCLC and specifically relapsed disease, where I focused primarily on work with amrubicin.

Here is the slide set, the transcript, a link to the audio (mp3) version, and then the video podcast presentation. More topics to come.

[powerpress]

cancer-lifeline-talk-part-1-sclc-figures

cancer-lifeline-talk-part-1-sclc-transcript

Audio version Cancer Lifeline Talk Part 1 SCLC

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora